Actively Recruiting
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Led by University Hospital Muenster · Updated on 2023-09-13
30
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are monitoring the outcomes of using a triple inner branched aortic arch stentgraft in patients with aortic arch conditions such as aneurysms and dissections. This prospective, multicenter registry aims to collect new information about treatment planning and management for these aortic arch pathologies. The study observes patients treated with the triple inner branched arch stentgraft device from Terumo Aortic. The focus is on evaluating the procedure's feasibility, including cannulation and stentgrafting of the three branches, as well as tracking complications during and after the intervention. Follow-up assessments continue for up to three years to monitor long-term outcomes. Participants will be followed closely with evaluations including mortality and stroke rates 30 days after the procedure and during the three-year follow-up period. Researchers will also assess morbidity, endoleaks, patency of the stented branches, and long-term survival. Patients will need to be available for follow-up visits and provide informed consent to participate in this observational study.
CONDITIONS
Brief Title
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Presence of aortic arch pathology
- Treatment planned with triple inner branch from Terumo Aortic
- Availability of the patient during the follow-up period
- Patients informed about the study and provided written informed consent
You will not qualify if you...
- Women of childbearing age
- Patients under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During intervention
Participants receive the triple inner branched arch stentgraft device as part of their treatment planning and management for aortic arch pathologies.
1 intervention visit
Duration - Up to 3 years
Participants are monitored for outcomes including mortality, stroke, morbidity, endoleaks, patency of branches, and long-term safety during a follow-up period.
Regular follow-up visits during the 3-year period
Trial Site Locations
Total: 1 location
1
Muenster University Hospital
Münster, Germany
Actively Recruiting
Research Team
A
Alexander Oberhuber, MD, PhD
V
vascular trial unit
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here